Lilian Abbo, MD, chief, infection prevention & control and antibiotic stewardship, Jackson Health System, associate professor of clinical medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, explains why diagnostic tests may yield false positives.
Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, discusses the benefits of repurposing drugs for emerging infectious diseases rather than going down the very long, costly road of developing new ones.
Nicola Thompson, PhD, Epidemiologist, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), discusses the next step in implementing a prevalence survey to estimate national burden of HAIs in US nursing homes.
Lauri A. Hicks, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses how more data is needed to provide dentists with better guidelines for prescribing antibiotics.
The CDC offers insight into why a rare exception to the general recommendation of either brand of MenB vaccine had been made for the Rutgers outbreak in 2016.
Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, explains why stewards should think outside of the box when coming up with interventions to include in an antimicrobial stewardship program.
Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, explains how her future research aims to understand the effects of ceftazidime-avibactam in different patient populations.
Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains the impact of respiratory viral infections in children.
Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the potential consequences of prescribing unneeded antibiotics.
Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, discusses five stewardship strategies to help reduce healthcare-associated Clostridium difficile rates.
Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, shares an effective stewardship intervention for ruling out if someone is allergic to penicillin.
Annelies Wilder-Smith, MD, PhD, professor at Lee Kong Chian School of Medicine in Singapore, discusses the strain of Zika that hit Singapore in 2016.
Silvia Munoz-Price, MD, PhD, Associate Professor of Clinical Medicine at the Institute for Health and Society, Medical College of Wisconsin, and Enterprise Epidemiologist for Froedtert & the Medical College of Wisconsin, discusses some issues that she believes the subspecialty needs to address.
Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains a strategy used at his healthcare facility to prevent respiratory viral HAIs in children.
Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses what we know about antibiotic prescribing habits among dentists.
David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains how congenital infection with Zika virus differs from congenital infection with other viruses.
Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, discusses the significance of the findings of her research on Ceftazidime-Avibactam.
Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains how families and visitors can play a role in transmitting healthcare-associated infections.
Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, discusses how antibiotic allergies can affect stewardship.
David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains his research, which focuses on mechanisms of transmission of the Zika virus from mother to child.
Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses the aggressiveness of infection prevention strategies to stop Clostridium difficile outbreaks.
Lilian Abbo, MD, chief, infection prevention & control and antibiotic stewardship, Jackson Health System, associate professor of clinical medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, explains the importance of rapid diagnostic testing.
Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, explains how researchers can anonymously enter patient data to the international Zika virus registry, which collects data on women exposed to the mosquito-borne virus during pregnancy.
Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, discusses some points to be mindful of when considering IV to PO conversions.
Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, discusses limitations to C. difficile testing that could impact stewardship practices in healthcare facilities.
Robert Bransfield, MD, DLFAPA, Associate Clinical Professor, Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, examines the clinical and laboratory definitions of Lyme disease.
Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, explains why it is important that antibiotic stewards understand pharmacokinetics and pharmacodynamics.
Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, explains the importance of involving nurses in antimicrobial and antibiotic stewardship programs in hospitals.
Robert Bransfield, MD, DLFAPA, Associate Clinical Professor, Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, discusses the existence of chronic Lyme disease.
Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, explains an area of debate in the general medical field regarding antibiotics.
